NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today announced the Premarket Approval (PMA) ...

Allurion Technologies (ALUR) announced the presentation of two abstracts at Obesity Week, the annual meeting of The Obesity Society. The first abstract comprises outcomes data from Allurion’s largest ...

Anticipated procedural volumes growth of 20%, reflecting increased penetration in key direct markets and reallocation of marketing spend to more efficient channels Revenue of $60 to $65 million, ...

Allurion Technologies (ALUR) has received a new Buy rating, initiated by Jefferies analyst, Matthew Taylor. Matthew Taylor’s Buy rating for Allurion Technologies is grounded in a strong conviction ...

Following the closing of the Business Combination, Allurion Technologies Holdings, Inc., a wholly-owned subsidiary of Allurion and the surviving corporation following the consummation of the Business ...

If weight loss with drugs that must be self-injected weekly doesn’t sound appealing — think Ozempic, Wegovy and Zepbound — there may be an intriguing new option available down the road. It's “the ...

All Compute Health Acquisition Corp. Stockholders Encouraged to Vote “FOR” all Proposals to be Presented at the Warrant Holder Meeting Following the closing of the Business Combination, Allurion ...

Allurion Technologies ALUR will release its quarterly earnings report on Wednesday, 2025-08-13. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Allurion ...

The latest price target for Allurion Technologies (NYSE:ALUR) was reported by Chardan Capital on March 27, 2025. The analyst firm set a price target for $2.50 expecting ALUR to rise to within 12 ...

Hello, and welcome to the Allurion Third Quarter Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer ...

Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a one-for-twenty ...

If weight loss with drugs that must be self-injected weekly doesn’t sound appealing — think Ozempic, Wegovy and Zepbound — there may be an intriguing new option available down the road. It's “the ...